What About Tachycardia-induced Cardiomyopathy?

Login or register to view PDF.
Abstract

Long-standing tachycardia is a well-recognised cause of heart failure and left ventricular dysfunction, and has led to the nomenclature, tachycardia-induced cardiomyopathy (TIC). TIC is generally a reversible cardiomyopathy if the causative tachycardia can be treated effectively, either with medications, surgery or catheter ablation. The diagnosis is usually made after demonstrating recovery of left ventricular function with normalisation of heart rate in the absence of other identifiable aetiologies. One hundred years after the first reported case of TIC, our understanding of the pathophysiology of TIC in humans remains limited despite extensive work in animal models of TIC. In this review we will discuss the proposed mechanisms of TIC, the causative tachyarrhythmias and their treatment, outcomes for patients diagnosed with TIC, and future directions for research and clinical care.

Disclosure
The authors have no conflicts of interest to declare.
Correspondence
Mark E Josephson, Herman C. Dana Professor of Medicine, Harvard Medical School, Chief of the Cardiovascular Division, Beth Israel Deaconess Medical Center, Director, Harvard-Thorndike Electrophysiology Institute and Arrhythmia Service, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215, US. E: mjoseph2@bidmc.harvard.edu
Received date
28 April 2013
Accepted date
29 September 2013
Correspondence
Mark E Josephson, Herman C. Dana Professor of Medicine, Harvard Medical School, Chief of the Cardiovascular Division, Beth Israel Deaconess Medical Center, Director, Harvard-Thorndike Electrophysiology Institute and Arrhythmia Service, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215, US. E: mjoseph2@bidmc.harvard.edu
DOI
http://dx.doi.org/10.15420/aer.2013.2.2.82
References
  1. Gossage AM, Braxton Hicks JA. On auricular fibrillation.
    QJ Med 1913;6:435-40.
  2. Brill IC. Auricular fibrillation with congestive failure and
    no other evidence of organic heart disease. Am Heart J
    1937;13:175-82.
  3. Parkinson J, Campbell M. Paroxysmal auricular fibrillation:
    a record of two hundred patients. Q J Med 1930;24:67-100.
  4. Phillips E, Levine S. Auricular fibrillation without other
    evidence of heart disease: a cause of reversible heart failure.
    Am J Med 1949;7:478-89.
  5. Grogan M, Smith HC, Gersh BJ, Wood DL. Left ventricular
    dysfunction due to atrial fibrillation in patients initially
    believed to have idiopathic dilated cardiomyopathy. Am J
    Cardiol 1992;69:1570-3.
  6. Manolis AG, Katsivas AG, Lazaris EE, et al. Ventricular
    performance and quality of life in patients who underwent
    radiofrequency AV junction ablation and permanent
    pacemaker implantation due to medically refractory atrial
    tachyarrhythmias. J Interv Card Electrophysiol 1998;2:71-6.
  7. Raymond RJ, Lee AJ, Messineo FC, et al. Cardiac performance
    early after cardioversion from atrial fibrillation. Am Heart J
    1998;136:435-42.
  8. Luchsinger JA, Steinberg JS. Resolution of cardiomyopathy
    after ablation of atrial flutter. J Am Coll Cardiol
    1998;32:205-10.
  9. Chiladakis JA, Vassilikos VP, Maounis TN, et al. Successful
    radiofrequency catheter ablation of automatic atrial
    tachycardia with regression of the cardiomyopathy picture.
    Pacing Clin Electrophysiol 1997;20:953-9.
  10. Cruz FE, Cheriex EC, Smeets JL, et al. Reversibility of
    tachycardia-induced cardiomyopathy after cure of incessant
    supraventricular tachycardia. J Am Coll Cardiol
    1990;16:739-44.
  11. Gillette PC, Smith RT, Garson A Jr, et al. Chronic
    supraventricular tachycardia. A curable cause of congestive
    cardiomyopathy. JAMA 1985;253:391-2.
  12. Noë P, Van Driel V, Wittkampf F, Sreeram N. Rapid recovery
    of cardiac function after catheter ablation of persistent
    junctional reciprocating tachycardia in children. Pacing Clin
    Electrophysiol 2002;25:191-4.
  13. Anselme F, Boyle N, Josephson M. Incessant fascicular
    tachycardia: a cause of arrhythmia induced cardiomyopathy.
    Pacing Clin Electrophysiol 1998;21:760-3.
  14. Jaggarao NS, Nanda AS, Daubert JP. Ventricular tachycardia
    induced cardiomyopathy: improvement with radiofrequency
    ablation. Pacing Clin Electrophysiol 1996;19:505-8.
  15. Singh B, Kaul U, Talwar KK, Wasir HS. Reversibility of
    ÔÇ£tachycardia induced cardiomyopathyÔÇØ following the cure of
    idiopathic left ventricular tachycardia using radiofrequency
    energy. Pacing Clin Electrophysiol 1996;19:1391-2.
  16. Vijgen J, Hill P, Biblo LA, Carlson MD. Tachycardia-induced
    cardiomyopathy secondary to right ventricular outflow tract
    ventricular tachycardia: improvement of left ventricular systolic
    function after radiofrequency catheter ablation of the arrhythmia.
    J Cardiovasc Electrophysiol 1997;8:445-50.
  17. Chugh SS, Shen WK, Luria DM, Smith HC. First evidence of
    premature ventricular complex-induced cardiomyopathy:
    a potentially reversible cause of heart failure. J Cardiovasc
    Electrophysiol 2000;11:328-9.
  18. Whipple G, Sheffield L, Woodman E, et al. Reversible
    congestive heart failure due to chronic rapid stimulation of
    the normal heart. Proc N Engl Cardiovasc Soc 1962;
    20:39-40.
  19. Coleman HN 3rd, Taylor RR, Pool PE, et al. Congestive
    heart failure following chronic tachycardia. Am Heart J
    1971;81:790-8.
  20. Armstrong PW, Stopps TP, Ford SE, de Bold AJ. Rapid
    ventricular pacing in the dog: pathophysiologic studies of
    heart failure. Circulation 1986;74:1075-84.
  21. Wilson JR, Douglas P, Hickey WF, et al. Experimental
    congestive heart failure produced by rapid ventricular pacing
    in the dog: cardiac effects. Circulation 1987;75:857-67.
  22. Scott BD, Sharma MK, Levett JM, et al. Cardiac geometry and
    mass changes associated with pacing-induced cardiomyopathy
    in the dog. Am Heart J 1993;125:1047-53.
  23. Spinale FG, Hendrick DA, Crawford FA, et al. Chronic
    supraventricular tachycardia causes ventricular
    dysfunction and subendocardial injury in swine. Am J Physiol
    1990;259:H218-29.
  24. Thackray SD, Witte KK, Nikitin NP, et al. The prevalence of heart
    failure and asymptomatic left ventricular systolic dysfunction in
    a typical regional pacemaker population. Eur Heart J
    2003;24:1143-52.
  25. Wilkoff BL, Cook JR, Epstein AE, et al. Dual-chamber pacing
    or ventricular backup pacing in patients with an implantable
    defibrillator: the Dual Chamber and VVI Implantable
    Defibrillator (DAVID) Trial. JAMA 2002;288:3115-23.
  26. Gardiwal A, Yu H, Oswald H, et al. Right ventricular pacing is
    an independent predictor for ventricular tachycardia/
    ventricular fibrillation occurrence and heart failure events in
    patients with an implantable cardioverter-defibrillator. Europace
    2008;10:358-63.
  27. Delgado V, Tops LF, Trines SA, et al. Acute effects of right
    ventricular apical pacing on left ventricular synchrony and
    mechanics. Circ Arrhythm Electrophysiol 2009;2:135-45.
  28. Lee SJ, McCulloch C, Mangat I, et al. Isolated bundle branch
    block and left ventricular dysfunction. J Card Fail 2003;9:87-92.
  29. Blanc JJ, Fatemi M, Bertault V, et al. Evaluation of left bundle
    branch block as a reversible cause of non-ischaemic dilated
    cardiomyopathy with severe heart failure. A new concept
    of left ventricular dyssynchrony-induced cardiomyopathy.
    Europace 2005;7:604-10.
  30. Udink ten Cate FE, Kruessell MA, Wagner K, et al. Dilated
    cardiomyopathy in children with ventricular preexcitation:
    the location of the accessory pathway is predictive of this
    association. J Electrocardiol 2010;43:146-54.
  31. Cadrin-Tourigny J, Fournier A, Andelfinger G, Khairy P. Severe
    left ventricular dysfunction in infants with ventricular
    preexcitation. Heart rhythm 2008;5:1320-2.
  32. Shinbane JS, Wood MA, Jensen DN, et al. Tachycardia-induced
    cardiomyopathy: a review of animal models and clinical
    studies. J Am Coll Cardiol 1997;29:709-15.
  33. Damiano RJ Jr, Tripp HF Jr, Asano T, et al. Left ventricular
    dysfunction and dilatation resulting from chronic
    supraventricular tachycardia. J Thorac Cardiovasc Surg
    1987;94:135-43.
  34. Moe GW, Stopps TP, Howard RJ, Armstrong PW. Early
    recovery from heart failure: insights into the pathogenesis of
    experimental chronic pacing-induced heart failure. J Lab Clin
    Med 1988;112:426-32.
  35. Redfield MM, Aarhus LL, Wright RS, Burnett JC Jr. Cardiorenal
    and neurohumoral function in a canine model of early left
    ventricular dysfunction. Circulation 1993;87:2016-22.
  36. Zupan I, Rakovec P, Budihna N, et al. Tachycardia induced
    cardiomyopathy in dogs; relation between chronic
    supraventricular and chronic ventricular tachycardia. Int J
    Cardiol 1996;56:75-81.
  37. Moe GW, Howard RJ, Grima EA, Armstrong PW. How does
    intermittent pacing modify the response to rapid ventricular
    pacing in experimental heart failure? J Card Fail 1995;
    1:223-8.
  38. Howard RJ, Moe GW, Armstrong PW. Sequential
    echocardiographic-Doppler assessment of left ventricular
    remodelling and mitral regurgitation during evolving experimental
    heart failure. Cardiovasc Res 1991;25:468-74.
  39. Shannon RP, Komamura K, Stambler BS, et al. Alterations
    in myocardial contractility in conscious dogs with dilated
    cardiomyopathy. Am J Physiol 1991;260:H1903-11.
  40. Ohno M, Cheng CP, Little WC. Mechanism of altered patterns
    of left ventricular filling during the development of congestive
    heart failure. Circulation 1994;89:2241-50.
  41. Howard RJ, Stopps TP, Moe GW, et al. Recovery from heart
    failure: structural and functional analysis in a canine model.
    Can J Physiol Pharmacol 1988;66:1505-12.
  42. Morgan DE, Tomlinson CW, Qayumi AK, et al. Evaluation of
    ventricular contractility indexes in the dog with left ventricular
    dysfunction induced by rapid atrial pacing. J Am Coll Cardiol
    1989;14:489-95; discussion 496-8.
  43. O'Brien PJ, Ianuzzo CD, Moe GW, et al. Rapid ventricular
    pacing of dogs to heart failure: biochemical and physiological
    studies. Can J Physiol Pharmacol 1990;68:34-9.
  44. Tanaka R, Spinale FG, Crawford FA, Zile MR. Effect of chronic
    supraventricular tachycardia on left ventricular function
    and structure in newborn pigs. J Am Coll Cardiol 1992;
    20:1650-60.
  45. Moe GW, Angus C, Howard RJ, et al. Evaluation of indices of
    left ventricular contractility and relaxation in evolving canine
    experimental heart failure. Cardiovasc Res 1992;26:362-6.
  46. Komamura K, Shannon RP, Ihara T, et al. Exhaustion of Frank-
    Starling mechanism in conscious dogs with heart failure.
    Am J Physiol 1993;265:H1119-31.
  47. Tibayan FA, Lai DT, Timek TA, et al. Alterations in left
    ventricular torsion in tachycardia-induced dilated
    cardiomyopathy. J Thorac Cardiovasc Surg 2002;124:43-9.
  48. Zellner JL, Spinale FG, Eble DM, et al. Alterations in
    myocyte shape and basement membrane attachment with
    tachycardia-induced heart failure. Circ Res 1991;69:590-600.
  49. Nakamura R, Egashira K, Machida Y, et al. Probucol
    attenuates left ventricular dysfunction and remodeling in
    tachycardia-induced heart failure: roles of oxidative stress
    and inflammation. Circulation 2002;106:362-7.
  50. Riegger AJ, Liebau G. The renin-angiotensin-aldosterone
    system, antidiuretic hormone and sympathetic nerve activity
    in an experimental model of congestive heart failure in the
    dog. Clin Sci (Lond) 1982;62:465-9.
  51. Moe GW, Stopps TP, Angus C, et al. Alterations in serum
    sodium in relation to atrial natriuretic factor and other
    neuroendocrine variables in experimental pacing-induced
    heart failure. J Am Coll Cardiol 1989;13:173-9.
  52. Moe GW, Canepa-Anson R, Armstrong PW. Atrial natriuretic
    factor: pharmacokinetics and cyclic GMP response in relation
    to biologic effects in severe heart failure. J Cardiovasc Pharmacol
    1992;19:691-700.
  53. Moe GW, Grima EA, Wong NL, et al. Dual natriuretic peptide
    system in experimental heart failure. J Am Coll Cardiol
    1993;22:891-8.
  54. Tomita M, Spinale FG, Crawford FA, Zile MR. Changes in
    left ventricular volume, mass, and function during the
    development and regression of supraventricular
    tachycardia-induced cardiomyopathy. Disparity between
    recovery of systolic versus diastolic function. Circulation
    1991;83:635-44.
  55. Jovanovic S, Grantham AJ, Tarara JE, et al. Increased number
    of cardiomyocytes in cross-sections from tachycardiainduced
    cardiomyopathic hearts. Int J Mol Med 1999;3:153-5.
  56. Kajstura J, Zhang X, Liu Y, et al. The cellular basis of
    pacing-induced dilated cardiomyopathy. Myocyte cell
    loss and myocyte cellular reactive hypertrophy. Circulation
    1995;92:2306-17.
  57. Spinale FG, Zellner JL, Tomita M, et al. Relation between
    ventricular and myocyte remodeling with the development
    and regression of supraventricular tachycardia-induced
    cardiomyopathy. Circ Res 1991;69:1058-67.
  58. Spinale FG, Grine RC, Tempel GE, et al. Alterations in
    the myocardial capillary vasculature accompany
    tachycardia-induced cardiomyopathy. Basic Res Cardiol
    1992;87:65-79.
  59. Shannon RP, Komamura K, Shen YT, et al. Impaired regional
    subendocardial coronary flow reserve in conscious dogs
    with pacing-induced heart failure. Am J Physiol 1993;
    265:H801-9.
  60. Heinke MY, Yao M, Chang D, et al. Apoptosis of ventricular
    and atrial myocytes from pacing-induced canine heart failure.
    Cardiovasc Res 2001;49:127-34.
  61. Spinale FG, Clayton C, Tanaka R, et al. Myocardial Na+,K(+)-
    ATPase in tachycardia induced cardiomyopathy. J Mol Cell
    Cardiol 1992;24:277-94.
  62. Khasnis A, Jongnarangsin K, Abela G, et al. Tachycardiainduced
    cardiomyopathy: a review of literature. Pacing Clin
    Electrophysiol 2005;28:710-21.
  63. Qin F, Shite J, Mao W, Liang CS. Selegiline attenuates cardiac
    oxidative stress and apoptosis in heart failure: association
    with improvement of cardiac function. Eur J Pharmacol
    2003;461:149-58.
  64. Shite J, Qin F, Mao W, et al. Antioxidant vitamins attenuate
    oxidative stress and cardiac dysfunction in tachycardiainduced
    cardiomyopathy. J Am Coll Cardiol 2001;38:1734-40.
  65. Marin-Garcia J, Goldenthal MJ, Moe GW. Selective endothelin
    receptor blockade reverses mitochondrial dysfunction in
    canine heart failure. J Card Fail 2002;8:326-32.
  66. Calderone A, Bouvier M, Li K, et al. Dysfunction of the betaand
    alpha-adrenergic systems in a model of congestive heart
    failure. The pacing-overdrive dog. Circ Res 1991;69:332-43.
  67. Marzo KP, Frey MJ, Wilson JR, et al. Beta-adrenergic
    receptor-G protein-adenylate cyclase complex in
    experimental canine congestive heart failure produced by
    rapid ventricular pacing. Circ Res 1991;69:1546-56.
  68. Yonemochi H, Yasunaga S, Teshima Y, et al. Rapid electrical
    stimulation of contraction reduces the density of betaadrenergic
    receptors and responsiveness of cultured
    neonatal rat cardiomyocytes. Possible involvement of
    microtubule disassembly secondary to mechanical stress.
    Circulation 2000;101:2625-30.
  69. Omichi C, Tanaka T, Kakizawa Y, et al. Improvement of cardiac
    function and neurological remodeling in a patient with
    tachycardia-induced cardiomyopathy after catheter ablation.
    J Cardiol 2009;54:134-8.
  70. Umana E, Solares CA, Alpert MA. Tachycardia-induced
    cardiomyopathy. Am J Med 2003;114:51-5.
  71. Perreault CL, Shannon RP, Komamura K, et al. Abnormalities
    in intracellular calcium regulation and contractile function in
    myocardium from dogs with pacing-induced heart failure.
    J Clin Invest 1992;89:932-8.
  72. Wolff MR, Whitesell LF, Moss RL. Calcium sensitivity of
    isometric tension is increased in canine experimental heart
    failure. Circ Res 1995;76:781-9.
  73. Balijepalli RC, Lokuta AJ, Maertz NA, et al. Depletion of
    T-tubules and specific subcellular changes in sarcolemmal
    proteins in tachycardia-induced heart failure. Cardiovasc Res
    2003;59:67-77.
  74. Lacroix D, Gluais P, Marqui├® C, et al. Repolarization
    abnormalities and their arrhythmogenic consequences in
    porcine tachycardia-induced cardiomyopathy. Cardiovasc Res
    2002;54:42-50.
  75. Pak PH, Nuss HB, Tunin RS, et al. Repolarization abnormalities,
    arrhythmia and sudden death in canine tachycardia-induced
    cardiomyopathy. J Am Coll Cardiol 1997;30:576-84.
  76. Yamamoto K, Burnett JC Jr, Meyer LM, et al. Ventricular
    remodeling during development and recovery from modified
    tachycardia-induced cardiomyopathy model. Am J Physiol
    1996;271:R1529-34.
  77. Spinale FG, Holzgrefe HH, Mukherjee R, et al. LV and
    myocyte structure and function after early recovery
    from tachycardia-induced cardiomyopathy. Am J Physiol
    1995;268:H836-47.
  78. Spinale FG, Tomita M, Zellner JL, et al. Collagen remodeling
    and changes in LV function during development and recovery
    from supraventricular tachycardia. Am J Physiol 1991;
    261:H308-18.
  79. Huizar JF, Kaszala K, Potfay J, et al. Left ventricular systolic
    dysfunction induced by ventricular ectopy: a novel model for
    premature ventricular contraction-induced cardiomyopathy.
    Circ Arrhythm Electrophysiol 2011;4:543-9.
  80. Krapp M, Gembruch U, Baumann P. Venous blood flow pattern
    suggesting tachycardia-induced 'cardiomyopathy' in the
    fetus. Ultrasound Obstet Gynecol 1997;10:32-40.
  81. Dhala A, Thomas JP. Images in cardiovascular medicine.
    Reversible tachycardia-induced cardiomyopathy. Circulation
    1997;95:2327-8.
  82. Sanchez C, Benito F, Moreno F. Reversibility of tachycardiainduced
    cardiomyopathy after radiofrequency ablation of
    incessant supraventricular tachycardia in infants. Br Heart J
    1995;74:332-3.
  83. De Giovanni JV, Dindar A, Griffith MJ, et al. Recovery pattern
    of left ventricular dysfunction following radiofrequency
    ablation of incessant supraventricular tachycardia in infants
    and children. Heart 1998;79:588-92.
  84. Stewart S, Hart CL, Hole DJ, McMurray JJ. A population-based
    study of the long-term risks associated with atrial fibrillation:
    20-year follow-up of the Renfrew/Paisley study. Am J Med
    2002;113:359-64.
  85. Shapiro W, Klein G. Alterations in cardiac function immediately
    following electrical conversion of atrial fibrillation to normal
    sinus rhythm. Circulation 1968;38:1074-84.
  86. Lipkin DP, Frenneaux M, Stewart R, et al. Delayed
    improvement in exercise capacity after cardioversion of atrial
    fibrillation to sinus rhythm. Br Heart J 1988;59:572-7.
  87. Atwood JE, Myers J, Sullivan M, et al. The effect of
    cardioversion on maximal exercise capacity in patients with
    chronic atrial fibrillation. Am Heart J 1989;118:913-8.
  88. Sacrez A, Kieny JR, Bouhour JB, et al. [Effect of cardioversion
    of atrial fibrillation on left ventricular function in dilated
    cardiomyopathy. A multicenter study]. Arch Mal Coeur Vaiss
    1990;83:15-21.
  89. Van Gelder IC, Crijns HJ, Blanksma PK, et al. Time course
    of hemodynamic changes and improvement of exer